The largest database of trusted experimental protocols

Mouse ril 33

Manufactured by R&D Systems

Mouse rIL-33 is a recombinant protein that corresponds to the full-length sequence of the mouse interleukin-33 (IL-33) cytokine. IL-33 is a member of the IL-1 family of cytokines and functions as an important mediator of type 2 immune responses.

Automatically generated - may contain errors

4 protocols using mouse ril 33

1

Intranasal Allergen Challenge in Pla2g5-Null Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57/BL6 Wt and Pla2g5-null mice48 (link), 49 (link) (9–12 wk-old males) received 25 μg of Alternaria alternata extract (Greer Laboratories, Lenoir, NC) in 20 uL of PBS or PBS alone intranasally (i.n.) on days 0,3,6 and 9 and euthanized 18h later1 (link) or a single dose of 100 μg and were euthanized after 1h or 3h2. Alternatively, Wt and Pla2g5-null naïve mice were given mouse rIL-33 (R&D Systems, Minneapolis, MN) i.n. 100 ng/dose on days 0,3,6 and 9 with or without LA (132 nM)28 (link) OA (106 nM) or AA (99 nM), and mice were euthanized 18h after the last dose. All animal experiments were approved by the Animal Care and Use Committee of the Dana-Farber Cancer Institute (Boston, MA).
+ Open protocol
+ Expand
2

Bone Marrow Derived Macrophage Polarization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow (BM) cells from the femur and tibia were isolated and red blood cells were lysed. BM cells were cultured in DMEM-F12 media supplemented with 10%FBS and 20% supernatant derived from CMG14–12 (M-CSF producing) cell line for 5–7 days prior to experiments. BMDM polarization was assessed by cell morphology and later confirmed by cell surface expression of CD64, F4/80, CD11b, and CD11c. For some experiments, BMDMs were exposed to neuron-derived supernatants overnight. On the day of experiment, cells were exposed to vehicle, 50 or 250ng/mL of LPS (Sigma-Aldrich) for 6–8hours. BD GolgiPlug™ Protein Transport Inhibitor (containing Brefeldin A) and BD GolgiStop Protein Transport Inhibitor (containing Monensin) were added in the last 5 hours of stimulation. Cells and supernatant were recovered to be analyzed for cytokine expression by flow cytometry and cytokine concentration by ELISA, respectively. For IL-1β release, BMDMs were treated with 250ng/mL of LPS (Sigma-Aldrich) for 4 hours followed by exposure to vehicle, 0.5 or 2.5mM of ATP(Sigma-Aldrich). Supernatants were assessed for cytokine concentration by ELISA. For some experiments, control BMDMs were treated with 500ng/mL of neutralizing anti-ST2 antibody (R&D systems) or CD11c-IL-33KO BMDMs were exposed to 500ng/mL of mouse rIL-33 (R&D systems) 24hours prior to LPS stimulation.
+ Open protocol
+ Expand
3

Streptococcal Skin Infection Air Pouch Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Groups of six WT, IL-33-KO, and ST2-KO mice were anesthetized by isoflurane inhalation and then injected subcutaneously with 1 mL of air to form an air pouch one day before the infection. One day later, 0.1 mL of bacterial suspension containing 3 × 108 S. pyogenes NZ131 cells was inoculated into the air pouch [48 (link)]. The animals were observed every day for a total of 13 days. Survival curves were then determined. At 48 h post-infection, the degrees of skin lesion were quantitated by an exudates-absorbed method, which is based on the premise that the more severe the skin damage, the more that the exudates will effuse. A Kimwipes (Kimberly-Clark Global Sales, Inc., Roswell, GA, USA) paper was attached to the air pouch area, and the wet area of the paper was then gauged [49 (link)]. The average lesion area in each group was generated by examination of skin lesions from six mice. After that, the skin lesion tissue around the air pouch was excised, fixed in 3.7% formaldehyde, and embedded in paraffin. The 5-µm-thick tissues were sliced and stained with hematoxylin and eosin. In some experiments, 0.1 mL of mouse rIL-33 (R&D Systems) (1 µg per mouse) and sST2 protein (R&D Systems) (1 µg per mouse) were injected into the air pouches of IL-33-KO mice and WT mice, respectively, at 30 min before GAS infection or 24 h post-infection.
+ Open protocol
+ Expand
4

Intranasal Allergen Challenge in Pla2g5-Null Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57/BL6 Wt and Pla2g5-null mice48 (link), 49 (link) (9–12 wk-old males) received 25 μg of Alternaria alternata extract (Greer Laboratories, Lenoir, NC) in 20 uL of PBS or PBS alone intranasally (i.n.) on days 0,3,6 and 9 and euthanized 18h later1 (link) or a single dose of 100 μg and were euthanized after 1h or 3h2. Alternatively, Wt and Pla2g5-null naïve mice were given mouse rIL-33 (R&D Systems, Minneapolis, MN) i.n. 100 ng/dose on days 0,3,6 and 9 with or without LA (132 nM)28 (link) OA (106 nM) or AA (99 nM), and mice were euthanized 18h after the last dose. All animal experiments were approved by the Animal Care and Use Committee of the Dana-Farber Cancer Institute (Boston, MA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!